The cost of pharmacovigilance: a time and motion study of an adverse drug reaction program

Int J Pharm Pract. 2021 Oct 18;29(5):521-523. doi: 10.1093/ijpp/riab037.

Abstract

Objectives: Adverse medication events are associated with a significant number of hospital admissions, and the appropriate recording of these events plays a vital role in medication safety. We set out to analyse the time and extrapolated cost in reporting adverse drug reactions (ADRs).

Methods: A time and motion study of the tasks involved in reviewing, assessing, reporting and communicating ADRs was done over a period of 2 months.

Key findings: We found a median of 69 min was needed in background work per ADR report.

Conclusion: The commitment involved in the support of this program is considerable and will encourage further refinement to streamline the process.

Keywords: adverse drug reactions; medication safety; pharmacists; pharmacovigilance.

MeSH terms

  • Adverse Drug Reaction Reporting Systems
  • Drug-Related Side Effects and Adverse Reactions* / epidemiology
  • Humans
  • Pharmacists
  • Pharmacovigilance*
  • Time and Motion Studies